Switch to:
Annual Rates (per share) 10 yrs* 5 yrs* 12 months*
Revenue Growth (%) 29.40  1.30  -1.70 
EBITDA Growth (%) 31.70  16.40  1.70 
EBIT Growth (%) 0.00  0.00  0.00 
Free Cash Flow Growth (%) 53.40  3.00  -13.50 
Book Value Growth (%) 0.00  2.30  507.40 

*12-month growth rate is calculated with the per share revenue (EBITDA, FCF, earnings) of the last 12 months over the per share revenue (EBITDA, FCF, earnings) over the previous 12 months. 5-year and 10-year growth rates are calculated with least-square regression based on the 5-year and 10-year numbers.
   Trendline:
Embed
Video Video Tutorial
Also traded in: UK, Germany
Export:Download financial data to ExcelDownload financial data to CSV Add to batch download listDownload 15-Y Financial PrintPrint This Table helpSee this page for the explanation of the data and charts * All numbers are in millions except for per share data
* Preliminary data is from the companies’ press releases. 10-Q/K data is not available yet. Preliminary data is not used in the calculation of Ratios, Scores, or Rankings.
Per Share DataAnnualsAdd to batch download listDownload 15Y FinancialQuarterly
Fiscal Period
Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 TTM Mar12 Jun12 Sep12 Dec12 Mar13
   
Revenue per Share ($)
0.79
5.23
13.87
24.15
25.23
18.19
18.78
18.49
20.08
20.03
20.88
5.55
4.81
5.08
5.16
5.83
EBITDA per Share ($)
0.25
1.97
4.67
7.29
7.91
3.91
6.50
6.95
7.96
8.06
8.45
2.05
1.93
2.09
2.20
2.23
EBIT per Share ($)
0.01
0.22
-0.14
0.07
0.10
-1.54
0.70
1.54
2.72
3.41
3.61
0.72
0.84
0.89
1.04
0.84
Earnings per Share (diluted) ($)
-0.11
-0.37
0.07
-3.57
-2.87
-4.15
-1.77
-0.67
0.37
14.14
14.89
0.03
0.34
0.66
13.19
0.69
eps without NRI ($)
-0.11
-0.37
0.07
-3.57
-2.87
-4.15
-1.77
-0.67
0.37
14.14
14.89
0.03
0.34
0.66
13.19
0.69
Free Cashflow per Share ($)
0.05
0.08
0.14
1.55
1.11
1.25
1.60
1.81
2.42
1.25
1.86
0.15
0.21
0.80
0.11
0.74
Dividends Per Share
--
--
--
--
0.13
0.13
0.17
0.16
0.16
0.16
0.16
0.04
0.04
0.04
0.04
0.04
Book Value Per Share ($)
-1.56
15.04
13.92
21.66
17.40
8.51
7.36
6.03
3.21
15.42
18.74
2.68
2.28
2.45
15.68
18.74
Tangible Book per share ($)
-1.84
12.56
12.14
-2.73
-3.06
-3.24
-4.18
-4.16
-6.94
5.57
7.46
-8.45
-7.17
-7.52
5.66
7.46
Month End Stock Price ($)
--
17.58
23.82
25.24
17.14
4.99
16.83
27.24
21.38
36.75
--
24.98
24.39
29.42
36.75
48.97
RatiosAnnualsAdd to batch download listDownload 15Y FinancialQuarterly
Fiscal Period
Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 TTM Mar12 Jun12 Sep12 Dec12 Mar13
   
Return on Equity %
--
--
20.71
-21.50
-15.57
-32.09
-22.29
-10.04
7.97
151.15
192.37
5.02
52.77
102.73
581.91
16.50
Return on Assets %
-4.82
-1.17
8.60
-6.81
-4.33
-7.58
-3.92
-1.54
0.91
31.40
34.22
0.36
3.30
6.48
116.55
5.04
Return on Capital - Joel Greenblatt %
0.84
1.09
-0.60
0.22
0.29
-5.21
2.86
6.43
11.54
15.61
15.82
11.46
15.51
16.06
18.44
12.86
Debt to Equity
-2.12
0.95
1.17
1.91
2.12
3.36
4.01
4.76
9.16
1.88
1.82
11.89
12.23
11.68
1.88
1.82
   
Gross Margin %
39.29
72.43
58.50
56.34
55.08
54.45
57.01
59.36
59.78
60.27
60.38
58.57
60.74
60.76
60.97
59.00
Operating Margin %
1.54
4.24
-1.01
0.27
0.41
-8.45
3.73
8.31
13.53
17.05
17.41
13.01
17.49
17.51
20.06
14.37
Net Margin %
-14.10
-6.91
21.62
-14.82
-11.38
-22.75
-9.40
-3.65
1.90
69.57
73.81
0.70
6.30
12.06
255.55
13.32
   
Total Equity to Total Asset
-0.66
0.44
0.39
0.29
0.27
0.19
0.16
0.14
0.08
0.30
0.31
0.06
0.06
0.06
0.30
0.31
LT Debt to Total Asset
0.02
0.40
0.46
0.54
0.57
0.63
0.65
0.66
0.73
0.56
0.56
0.74
0.74
0.74
0.56
0.56
   
Asset Turnover
0.34
0.17
0.40
0.46
0.38
0.33
0.42
0.42
0.48
0.45
0.46
0.13
0.13
0.13
0.11
0.10
Dividend Payout Ratio
--
--
--
--
--
--
--
--
0.42
0.01
0.01
1.25
0.11
0.06
0.00
0.06
   
Days Sales Outstanding
43.02
77.42
35.95
46.73
40.82
41.52
41.05
40.61
39.81
39.50
36.21
38.57
39.73
40.56
38.95
37.46
Days Accounts Payable
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
Days Inventory
--
--
--
7.58
13.86
19.03
17.39
12.10
4.49
1.42
0.48
1.41
--
--
--
--
Cash Conversion Cycle
43.02
77.42
35.95
54.31
54.68
60.55
58.44
52.71
44.30
40.92
36.69
39.98
39.73
40.56
38.95
37.46
Inventory Turnover
--
--
--
48.17
26.34
19.18
20.99
30.16
81.30
257.57
756.80
64.56
--
--
--
--
COGS to Revenue
0.61
0.28
0.42
0.44
0.45
0.46
0.43
0.41
0.40
0.40
0.40
0.41
0.39
0.39
0.39
0.41
Inventory to Revenue
--
--
--
0.01
0.02
0.02
0.02
0.01
0.01
0.00
0.00
0.01
--
--
--
--
Income StatementAnnuals (USD $) View: Quarterly
Fiscal Period
Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 TTM Mar12 Jun12 Sep12 Dec12 Mar13
   
Revenue
2,273
1,281
3,398
7,075
8,221
5,967
6,176
6,046
6,227
6,624
6,507
1,592
1,597
1,658
1,680
1,572
Cost of Goods Sold
1,380
353
1,410
3,089
3,693
2,718
2,655
2,457
2,505
2,632
2,578
660
627
650
656
645
Gross Profit
893
928
1,988
3,986
4,528
3,249
3,521
3,589
3,723
3,992
3,929
932
970
1,007
1,024
928
Gross Margin %
39.29
72.43
58.50
56.34
55.08
54.45
57.01
59.36
59.78
60.27
60.38
58.57
60.74
60.76
60.97
59.00
   
Selling, General, & Admin. Expense
858
446
886
1,781
1,996
1,314
1,312
1,233
1,242
1,321
1,291
337
329
325
310
327
Advertising
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
Research & Development
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
Other Operating Expense
-0
428
1,136
2,185
2,499
2,439
1,978
1,854
1,638
1,542
1,506
389
362
391
377
375
Operating Income
35
54
-34
19
34
-504
231
502
843
1,129
1,133
207
279
290
337
226
Operating Margin %
1.54
4.24
-1.01
0.27
0.41
-8.45
3.73
8.31
13.53
17.05
17.41
13.01
17.49
17.51
20.06
14.37
   
Interest Income
42
21
51
68
39
41
10
13
129
--
10
0
9
0
--
--
Interest Expense
-855
-185
-411
-898
-1,038
-733
-739
-745
-688
-644
-602
-167
-153
-162
-152
-135
Other Income (Minority Interest)
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
Pre-Tax Income
-292
-89
-387
-1,025
-930
-1,367
-548
-458
145
422
650
11
101
200
105
244
Tax Provision
-28
--
-33
23
-5
10
4
194
-25
4,186
4,152
-0
-0
-1
4,187
-34
Tax Rate %
-9.58
--
-8.47
2.26
-0.54
0.74
0.74
42.31
17.19
-991.28
-638.46
1.41
0.46
0.32
-3,987.69
14.05
Net Income (Continuing Operations)
-320
-89
-422
-1,000
-935
-1,358
-544
-264
120
4,608
4,802
11
101
200
4,292
210
Net Income (Discontinued Operations)
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
Net Income
-320
-89
735
-1,049
-935
-1,358
-581
-221
118
4,608
4,802
11
101
200
4,292
210
Net Margin %
-14.10
-6.91
21.62
-14.82
-11.38
-22.75
-9.40
-3.65
1.90
69.57
73.81
0.70
6.30
12.06
255.55
13.32
   
Preferred dividends
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
EPS (Basic)
-0.11
-0.37
0.07
-3.57
-2.87
-4.15
-1.77
-0.67
0.37
16.80
17.83
0.03
0.36
0.74
15.96
0.77
EPS (Diluted)
-0.11
-0.37
0.07
-3.57
-2.87
-4.15
-1.77
-0.67
0.37
14.14
14.89
0.03
0.34
0.66
13.19
0.69
Shares Outstanding (Diluted)
2,874.0
245.0
245.0
292.9
325.9
328.0
328.8
327.1
310.1
330.8
269.8
286.8
332.2
326.5
325.4
269.8
   
Depreciation, Depletion and Amortization
681
429
1,178
2,117
2,545
1,786
1,905
1,771
1,625
1,537
1,509
380
362
393
380
375
EBITDA
716
483
1,144
2,137
2,579
1,282
2,136
2,273
2,468
2,667
2,642
587
642
683
717
600
Balance SheetAnnuals (USD $) View: Quarterly
Fiscal Period
Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Latest Q. Mar12 Jun12 Sep12 Dec12 Mar13
   
  Cash And Cash Equivalents
748
131
1,283
822
649
270
699
748
469
333
481
223
297
183
333
481
  Marketable Securities
23
--
169
--
--
250
4
1
15
--
--
12
--
--
--
--
Cash, Cash Equivalents, Marketable Securities
771
131
1,452
822
649
520
702
749
483
333
481
223
297
183
333
481
Accounts Receivable
268
272
335
906
919
679
695
673
679
717
646
673
695
737
717
646
  Inventories, Raw Materials & Components
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
  Inventories, Work In Process
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
  Inventories, Inventories Adjustments
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
  Inventories, Finished Goods
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
  Inventories, Other
--
--
--
252
307
195
198
64
32
--
--
--
--
--
--
--
Total Inventories
--
--
--
128
152
131
122
41
20
--
--
--
--
--
--
--
Other Current Assets
28
84
202
183
204
177
173
142
134
265
254
162
159
177
265
254
Total Current Assets
1,067
486
1,989
2,039
1,924
1,507
1,692
1,605
1,317
1,315
1,380
1,058
1,151
1,096
1,315
1,380
   
  Land And Improvements
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
  Buildings And Improvements
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
  Machinery, Furniture, Equipment
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
  Construction In Progress
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
Gross Property, Plant and Equipment
4,240
6,124
8,834
16,707
16,352
13,063
15,054
14,786
15,208
16,144
16,144
--
--
--
16,144
--
  Accumulated Depreciation
--
-385
-3,085
-4,871
-4,938
-5,117
-6,857
-7,355
-8,027
-8,855
-8,855
--
--
--
-8,855
--
Property, Plant and Equipment
4,240
5,739
5,749
11,836
11,414
7,946
8,197
7,431
7,180
7,289
6,765
7,275
7,130
7,333
7,289
6,765
Intangible Assets
783
606
436
7,143
6,670
3,852
3,795
3,332
3,147
3,259
3,043
3,192
3,138
3,254
3,259
3,043
Other Long Term Assets
722
1,551
530
1,064
1,115
1,401
1,231
1,412
740
5,106
5,111
690
767
810
5,106
5,111
Total Assets
6,811
8,382
8,704
22,083
21,122
14,707
14,915
13,780
12,385
16,970
16,299
12,215
12,186
12,494
16,970
16,299
   
  Accounts Payable
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
  Total Tax Payable
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
  Other Accrued Expense
172
179
817
1,699
1,572
1,510
1,607
1,498
1,361
1,328
1,243
1,390
1,295
1,393
1,328
1,243
Accounts Payable & Accrued Expense
172
179
817
1,699
1,572
1,510
1,607
1,498
1,361
1,328
1,243
1,390
1,295
1,393
1,328
1,243
Current Portion of Long-Term Debt
9,415
114
1
279
59
60
67
346
120
125
123
124
280
131
125
123
DeferredTaxAndRevenue
--
--
180
526
505
398
462
471
486
512
443
489
509
513
512
443
Other Current Liabilities
1,417
818
66
722
703
231
122
21
26
13
11
33
-0
--
13
11
Total Current Liabilities
11,004
1,111
1,064
3,227
2,839
2,199
2,258
2,336
1,993
1,977
1,821
2,036
2,084
2,037
1,977
1,821
   
Long-Term Debt
100
3,386
3,977
11,818
11,966
9,313
9,632
9,046
9,015
9,454
9,094
9,023
8,971
9,212
9,454
9,094
Debt to Equity
-2.12
0.95
1.17
1.91
2.12
3.36
4.01
4.76
9.16
1.88
1.82
11.89
12.23
11.68
1.88
1.82
  Capital Lease Obligation
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
  PensionAndRetirementBenefit
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
  NonCurrent Deferred Liabilities
189
202
16
152
163
340
430
329
296
273
263
289
273
273
273
263
Other Long-Term Liabilities
0
-1
236
542
481
63
173
97
84
165
67
97
101
172
165
67
Total Liabilities
11,292
4,698
5,293
15,739
15,450
11,915
12,494
11,807
11,388
11,869
11,244
11,446
11,429
11,694
11,869
11,244
   
Common Stock
503
2
1
4
4
3
2
3
2
2
2
2
2
2
2
2
Preferred Stock
14
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
Retained Earnings
-12,392
-89
-1,132
-2,339
-3,382
-3,891
-4,896
-4,990
-5,085
-803
-462
-5,202
-5,034
-5,076
-803
-462
Accumulated other comprehensive income (loss)
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
Additional Paid-In Capital
7,396
3,770
4,688
8,452
8,750
6,468
7,278
6,826
6,032
5,911
5,546
5,914
5,739
5,837
5,911
5,546
Treasury Stock
--
--
-199
--
--
--
--
--
--
--
--
--
--
--
--
--
Total Equity
-4,480
3,684
3,411
6,344
5,672
2,791
2,421
1,973
997
5,101
5,055
769
756
800
5,101
5,055
Total Equity to Total Asset
-0.66
0.44
0.39
0.29
0.27
0.19
0.16
0.14
0.08
0.30
0.31
0.06
0.06
0.06
0.30
0.31
Cashflow StatementAnnuals (USD $) View: Quarterly
Fiscal Period
Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 TTM Mar12 Jun12 Sep12 Dec12 Mar13
   
  Net Income
-320
-89
-422
-1,049
-935
-1,358
-581
-221
--
4,608
4,813
--
--
--
4,603
210
  Cumulative Effect Of Accounting Change
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
  Net Foreign Currency Exchange Gain
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
Net Income From Continuing Operations
-320
-89
-422
-1,049
-935
-1,358
-544
-264
120
4,608
4,802
11
101
200
4,292
210
Depreciation, Depletion and Amortization
681
429
1,178
2,117
2,545
1,786
1,905
1,771
1,625
1,537
1,509
380
362
393
380
375
  Change In Receivables
49
10
27
-137
9
-2
43
-44
-7
-14
-14
--
--
--
-14
--
  Change In Inventory
--
--
--
-43
-21
-19
10
-21
21
-7
-7
--
--
--
-7
--
  Change In Prepaid Assets
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
  Change In Payables And Accrued Expense
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
Change In Working Capital
--
-90
-247
340
-241
-75
-54
-4
-127
-114
-137
-40
-112
15
27
-68
Change In DeferredTax
40
--
36
-29
--
-3
5
-158
31
-4,181
-4,149
2
2
2
-4,188
34
Cash Flow from Discontinued Operations
--
--
--
--
--
--
-13
-47
-32
--
--
--
--
--
--
--
Cash Flow from Others
138
-11
-10
164
75
773
150
273
160
-171
-242
-18
5
-22
-137
-89
Cash Flow from Operations
539
240
536
1,544
1,445
1,123
1,449
1,572
1,776
1,680
1,784
336
359
588
375
462
   
Purchase Of Property, Plant, Equipment
-399
-220
-503
-1,090
-1,082
-713
-924
-980
-1,024
-1,265
-1,219
-291
-289
-327
-341
-263
Sale Of Property, Plant, Equipment
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
Purchase Of Business
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
Sale Of Business
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
Purchase Of Investment
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
Sale Of Investment
--
--
--
--
20
13
20
13
549
--
--
--
--
--
--
--
Net Intangibles Purchase And Sale
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
Cash From Discontinued Investing Activities
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
Cash Flow from Investing
-371
-197
2,046
-5,802
-1,029
-699
-929
-642
-491
-1,266
-1,214
-295
-287
-326
-340
-261
   
Issuance of Stock
--
--
9
76
30
--
--
--
--
--
--
--
--
--
--
--
Repurchase of Stock
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
Net Issuance of Preferred Stock
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
Net Issuance of Debt
--
-410
-1,372
3,604
-598
-592
-206
-262
-652
201
192
-31
110
-196
315
-36
Cash Flow for Dividends
--
--
--
-17
-43
-44
-54
-53
-49
-44
-43
-11
-11
-11
-11
-11
Other Financing
-103
47
-0
-0
-0
1
147
-294
129
-187
-172
0
0
2
-189
14
Cash Flow from Financing
-103
-362
-1,563
3,663
-610
-635
-113
-861
-1,562
-563
-299
-291
5
-386
115
-33
   
Net Change in Cash
65
-320
1,064
-622
-196
-208
404
76
-279
-152
272
-252
77
-125
150
169
Capital Expenditure
-399
-220
-503
-1,090
-1,082
-713
-924
-980
-1,024
-1,265
-1,219
-291
-289
-327
-341
-263
Free Cash Flow
140
19
33
454
363
410
525
591
752
414
564
44
71
261
34
198
Valuation Ratios (Daily)AnnualsQuarterly
Fiscal Period
Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Current Mar12 Jun12 Sep12 Dec12 Mar13
   
PE Ratio(ttm) Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only
Price to Tangible Book Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only
Price-to-Free-Cash-Flow ratio Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only
PS Ratio Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only
EV-to-Revenue Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only
EV-to-EBITDA Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only
EV-to-EBIT Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only
Earnings Yield (Joel Greenblatt) Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only
Forward Rate of Return Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only
Shiller PE Ratio Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only
Valuation and QualityAnnualsQuarterly
Fiscal Period
Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Current Mar12 Jun12 Sep12 Dec12 Mar13
   
Market Cap Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only
Enterprise Value Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only
Month End Stock Price Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only
Net Cash (per share) Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only
Net Current Asset Value (per share) Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only
Projected FCF (per share) Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only
Median PS (per share) Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only
Peter Lynch Fair Value (per share) Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only
Graham Number (per share) Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only
Earning Power Value (per share) Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only
Altman Z-Score Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only
Piotroski F-Score Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only
Beneish M-Score Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only
Sloan Ratio Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only
Highest Stock Price Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only
Lowest Stock Price Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only
Shares Buyback Ratio (%) Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only
YoY Rev. per Sh. Growth (%) Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only
YoY EPS Growth (%) Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only
YoY EBITDA Growth (%) Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only
Shares Outstanding (Basic) Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only
Shares Outstanding Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only
   
Forex Rate (USD/GBP) Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only
Download financial data to Excel Download financial data to CSV

GuruFocus has scanned the fundamental data of VMED and found 1 Severe Warning Sign, 4 Medium Warning Signs and Good Signs. Click here for details.

Change log: Dec. 19, 2014: Changed Income Statement format by moving 'EBITDA' and 'DDA' under 'Shares Outstanding (Diluted)'. For insurance companies, added 'Interest Expense' and 'Other Expense', as well as deleted 'Advertising' and 'Research &Development'. Dec. 18, 2014: Changed Income Statement format by moving 'EBITDA' and 'DDA' under 'Shares Outstanding (Diluted)'. For banks, moved 'SpecialCharges' under 'SGA' as a subset of 'SGA', as well as deleted 'Advertising' and 'Research &Development'. Dec. 1, 2014: Change 'Forex Rate' by using 12-01 monthly data as the Dec data. Nov. 19, 2014: Added 'Earning Power Value (per share)' below 'Graham Number (per share)'. Nov. 6, 2014: Added 'Cash Conversion Cycle' below 'Days Inventory'. Nov. 3, 2014: Added 'Days Accounts Payable' below 'Days Sales Outstanding'. Oct. 27, 2014: Added 'Shares Outstanding' below 'Shares Outstanding (Basic)'. Oct. 27, 2014: Moved 'Shares Outstanding (Basic)' below 'YoY EBITDA Growth (%)'. Oct. 16, 2014: Added 'Capital Expenditure' below 'Net Change in Cash'. Oct. 9, 2014: Added 'eps without NRI' below 'Earnings per Share (diluted)'. Oct. 9, 2014: Added 'Tangible Book per share' below 'Book Value Per Share'. Oct. 9, 2014: Added 'Sloan Ratio' below 'Beneish M-Score'. Sept. 26, 2014: Added 'DeferredTaxAndRevenue' above 'Other Current Liabilities', and remove its portion from 'Other Current Liabilities' during calculation. Sept. 26, 2014: Changed name of the field from 'DeferredTaxAndRevenue' to 'NonCurrent Deferred Liabilities'. Sept. 24, 2014: Income Statement added 'Tax Rate %' below 'Tax Provision'. Sept. 24, 2014: Balance Sheet: Added 'Debt to Equity' below 'Long Term Debt', and 'Total Equity to Total Asset' below 'Total Equity'. Sept. 24, 2014: Income Statement added 'Gross Margin %' below 'Gross Profit', 'Operating Margin %' below 'Operating Income', 'Net Margin %' below 'Net Income'. Sept. 24, 2014: Cash Flow Statement: 'Net Issuance of Stock' is seperated into two rows: 'Issuance of Stock', and 'Repurchase of Stock'. Feb. 10, 2014: added row 54 - Other operating charges, and row 106-Accumulated other comprehensive income (loss)

Switch to Another Stock:

cached

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK